RBR-5hvgtky尚未招募未知
utritional intervention to control Systemic Arterial Hypertension in Primary Health Care
niversidade Federal de Ouro Preto0 个研究点开始时间: 2021年12月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 20Y 至 0(—)
入选标准
- •Both sexes; over 20 years old
排除标准
- •Volunteers with cardiovascular disease, angina, heart attack, heart failure, atherosclerosis, peripheral vascular disease, ischemic cerebrovascular disease, chronic liver, kidney or infectious diseases evaluated by medical history; 10% change in body weight two months prior to the study; use of anti-inflammatory drugs; women on exogenous ovarian hormone replacement, pregnancy or breastfeeding; people with special needs; Alzheimer's disease, dementia or life expectancy shorter than study duration; cognitive difficulties.
研究者
相似试验
已完成
不适用
Vascular Intervention Program: a strategy of medication management for cardiovascular risk in people with type 2 diabetesType 2 diabetes mellitusNutritional, Metabolic, EndocrineDiabetes mellitus type 2ISRCTN97121854Canadian Diabetes Association400
已完成
不适用
Establishment of optimal treatment for vascular endothelial dysfunction in patients with lifestyle-related diseaseslifestyle-related diseasesJPRN-UMIN000020720Department of Community Medicine for Diabetes and Metabolic Disorders, Institute of Biomedical Sciences, Tokushima University Graduate School500
已完成
不适用
Management of patients with uncontrolled arterial hypertension - the role of electronic compliance monitoring, 24 hour ambulatory blood pressure monitoring and candesartan/hydrochlorothiazide (HCTZ)Resistant arterial hypertensionCirculatory SystemHypertensionISRCTN02311110Astra Zeneca (Germany)62
招募中
不适用
Percutaneous Complete Revascularization Strategies Using Sirolimus Eluting Biodegradable Polymer Coated Stents in Patients Presenting With Acute Coronary Syndromes and Multivessel Diseaseacute coronary syndromeNL-OMON54743Erasmus MC, Universitair Medisch Centrum Rotterdam794
已完成
不适用
Angiogenic Therapy Against Peripheral Arterial Disease with bone marrow derived MSC grown in platelet-rich plasmaPeripheral arterial diseaseJPRN-UMIN000021426ational Center for Global Health and Medicine5
